Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

Market Cap	6.88B -6.9%
Revenue (ttm)	3.65B -8.3%
Net Income	187.75M -22.9%
EPS	0.18 -25.0%
Shares Out	1.02B
PE Ratio	37.61
Forward PE	21.66
Dividend	0.12 (1.72%)
Ex-Dividend Date	n/a

Volume	5,825,700
Average Volume	6,253,316
Open	6.96
Previous Close	6.98
Day's Range	6.75 - 6.96
52-Week Range	6.38 - 9.42
Beta	1.36
RSI	49.82
Earnings Date	Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the production and sales of pharmaceuticals, raw materials, and additives in China. The company is involved in cosmetics and medicine businesses. It provides cleansers, lotions, creams, essences, masks, and other products. In addition, the company offers dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, and accelerates project research and investigation areas. Further, it serves hospitals, pharmacies, primary medical institutions, and chain drug stores, etc. The company was for...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 1993
• Employees: 3,630
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600223

Financial Performance

In 2025, SHA:600223's revenue was 3.65 billion, a decrease of -8.33% compared to the previous year's 3.98 billion. Earnings were 187.75 million, a decrease of -22.90%.